Roel Bakker
Roel Bakker
wetenschappelijk onderzoeker, Erasmus MC Rotterdam
Verified email at erasmusmc.nl
Title
Cited by
Cited by
Year
Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical …
JW Eaton, NA Menzies, J Stover, V Cambiano, L Chindelevitch, A Cori, ...
The Lancet Global Health 2 (1), e23-e34, 2014
1982014
Determinants of the impact of sexually transmitted infection treatment on prevention of HIV infection: a synthesis of evidence from the Mwanza, Rakai, and Masaka intervention …
EL Korenromp, RG White, KK Orroth, R Bakker, A Kamali, D Serwadda, ...
The Journal of infectious diseases 191 (Supplement_1), S168-S178, 2005
1682005
HIV and aging--preparing for the challenges ahead
MD Till Bärnighausen, JN MIA
The New England journal of medicine 366 (14), 1270, 2012
1512012
The impact of antiretroviral treatment on the age composition of the HIV epidemic in sub-Saharan Africa
JAC Hontelez, SJ de Vlas, R Baltussen, ML Newell, R Bakker, F Tanser, ...
AIDS (London, England) 26 (0 1), 2012
1342012
Elimination of HIV in South Africa through expanded access to antiretroviral therapy: a model comparison study
JAC Hontelez, MN Lurie, T Bärnighausen, R Bakker, R Baltussen, ...
PLoS Med 10 (10), e1001534, 2013
1292013
Proportion of new HIV infections attributable to herpes simplex 2 increases over time: simulations of the changing role of sexually transmitted infections in sub-Saharan …
EE Freeman, KK Orroth, RG White, JR Glynn, R Bakker, MC Boily, ...
Sexually transmitted infections 83 (suppl 1), i17-i24, 2007
1282007
Male circumcision for HIV prevention in sub-Saharan Africa: who, what and when?
RG White, JR Glynn, KK Orroth, EE Freeman, R Bakker, HA Weiss, ...
Aids 22 (14), 1841-1850, 2008
1112008
Can population differences explain the contrasting results of the Mwanza, Rakai, and Masaka HIV/sexually transmitted disease intervention trials?: A modeling study
RG White, KK Orroth, EL Korenromp, R Bakker, M Wambura, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 37 (4), 1500-1513, 2004
1052004
Understanding the differences between contrasting HIV epidemics in east and west Africa: results from a simulation model of the Four Cities Study
KK Orroth, EE Freeman, R Bakker, A Buvé, JR Glynn, MC Boily, RG White, ...
Sexually transmitted infections 83 (suppl 1), i5-i16, 2007
1002007
Treating curable sexually transmitted infections to prevent HIV in Africa: still an effective control strategy?
RG White, KK Orroth, JR Glynn, EE Freeman, R Bakker, JDF Habbema, ...
Journal of acquired immune deficiency syndromes (1999) 47 (3), 346, 2008
862008
Ageing with HIV in south africa
JAC Hontelez, MN Lurie, ML Newell, R Bakker, F Tanser, T Bärnighausen, ...
AIDS (London, England) 25 (13), 2011
852011
HIV dynamics and behaviour change as determinants of the impact of sexually transmitted disease treatment on HIV transmission in the context of the Rakai trial
EL Korenromp, R Bakker, SJ Vlas, RH Gray, MJ Wawer, D Serwadda, ...
Aids 16 (16), 2209-2218, 2002
712002
The impact of the new WHO antiretroviral treatment guidelines on HIV epidemic dynamics and cost in South Africa
JAC Hontelez, SJ De Vlas, F Tanser, R Bakker, T Bärnighausen, ...
PloS one 6 (7), e21919, 2011
692011
cAMP-mediated effects of ouabain and theophylline on paracellular ion selectivity
R Bakker, JA Groot
American Journal of Physiology-Gastrointestinal and Liver Physiology 246 (2 …, 1984
651984
Elimination of African onchocerciasis: modeling the impact of increasing the frequency of ivermectin mass treatment
LE Coffeng, WA Stolk, A Hoerauf, D Habbema, R Bakker, AD Hopkins, ...
PloS one 9 (12), e115886, 2014
612014
Empirical observations underestimate the proportion of human immunodeficiency virus infections attributable to sexually transmitted diseases in the Mwanza and Rakai sexually …
KK Orroth, RG White, EL Korenromp, R Bakker, J Changalucha, ...
Sexually transmitted diseases 33 (9), 536-544, 2006
532006
Population-level effect of potential HSV2 prophylactic vaccines on HIV incidence in sub-Saharan Africa
EE Freeman, RG White, R Bakker, KK Orroth, HA Weiss, A Buvé, ...
Vaccine 27 (6), 940-946, 2009
502009
Concerted efforts to control or eliminate neglected tropical diseases: how much health will be gained?
SJ de Vlas, WA Stolk, EA le Rutte, JAC Hontelez, R Bakker, DJ Blok, ...
PLoS neglected tropical diseases 10 (2), e0004386, 2016
472016
HIV spread and partnership reduction for different patterns of sexual behaviour‐a study with the microsimulation model STDSIM
EL Korenromp, C Van Vliet, R Bakker, SJ de Vlas, JDF Habbema
Mathematical Population Studies 8 (2), 135-173, 2000
432000
VIP, serotonin, and epinephrine modulate the ion selectivity of tight junctions of goldfish intestine.
R Bakker, K Dekker, HR Jonge, JA Groot
American Journal of Physiology - Regulatory, Integrative and Comparative …, 1993
391993
The system can't perform the operation now. Try again later.
Articles 1–20